South Korean military personnel benefited slightly from an inactivated hantavirus vaccine, which was moderately effective in providing protection against hemorrhagic fever with renal syndrome, or HFRS, according to findings published in the Journal of Infectious Diseases. The vaccine was given to military personnel in divisions or battalions in which HFRS was reported within the past three years.
Study tests hantavirus vaccine on military patients
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.